Cytokeratin expression patterns in normal and malignant urothelium: a review of the biological and diagnostic implications

Citation
J. Southgate et al., Cytokeratin expression patterns in normal and malignant urothelium: a review of the biological and diagnostic implications, HIST HISTOP, 14(2), 1999, pp. 657-664
Citations number
56
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
HISTOLOGY AND HISTOPATHOLOGY
ISSN journal
02133911 → ACNP
Volume
14
Issue
2
Year of publication
1999
Pages
657 - 664
Database
ISI
SICI code
0213-3911(199904)14:2<657:CEPINA>2.0.ZU;2-O
Abstract
The cytokeratins are the intermediate filament proteins characteristic of e pithelial cells. In human cells, some 20 different cytokeratin isotypes hav e been identified. Epithelial cells express between two and ten cytokeratin isotypes and the consequent profile which reflects both epithelial type an d differentiation status may be useful in tumour diagnosis. The transitiona l epithelium or urothelium of the urinary tract shows alterations in the ex pression and configuration of cytokeratin isotypes related to stratificatio n and differentiation. In transitional cell carcinoma, changes in cytokerat in profile may provide information of potential diagnostic and prognostic s ignificance. The intensification of immunolabelling with some CK8 and CK18 antibodies may underly an active role in tumour invasion and foci of CK17-p ositive cells may represent proliferating populations. Loss of CK13 is a ma rker of grade and stage and de novo expression of CK14 is indicative of squ amous differentiation and an unfavourable prognosis. However, perhaps the m ost important recent finding is the demonstration that a normal CK20 expres sion pattern is predictive of tumour non-recurrence and can be used to make an objective differential diagnosis between transitional cell papilloma an d carcinoma. This review will consider cytokeratin expression in urothelium and discuss the application of cytokeratin typing to the diagnosis and pro gnosis of patients with TCC.